rosiglitazone has been researched along with dimethylarginine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, CP; Jiang, JL; Li, YJ; Wang, S; Yang, DL; Zhang, XJ | 1 |
| Chen, MF; Chen, WJ; Cheng, WC; Lee, YT; Lin, JW; Wang, TD | 1 |
1 trial(s) available for rosiglitazone and dimethylarginine
| Article | Year |
|---|---|
Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome.
Topics: Arginine; Blood Pressure; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Endothelin-1; Endothelium-Dependent Relaxing Factors; Female; Glucose; Humans; Insulin; Male; Metabolic Syndrome; Middle Aged; Regression Analysis; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vasodilator Agents | 2006 |
1 other study(ies) available for rosiglitazone and dimethylarginine
| Article | Year |
|---|---|
Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells.
Topics: Acetylcholine; Animals; Aorta; Arginine; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Male; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide Synthase; Nitrites; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Vasodilation | 2007 |